Skip to main content
Signal8
Patel Tushar Bhikhubhai profile photo

Tushar Bhikhubhai Patel

CIK: 0001745375

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)1 (50.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)1 (50.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

Amneal Pharmaceuticals, Inc. logo
AMRX

Amneal Pharmaceuticals, Inc.

10% Owner

Discretionary Trading P&L

Holdings

Transaction History (2 total)

  • Amneal Pharmaceuticals, Inc. logo
    AMRX

    Amneal Pharmaceuticals, Inc.

    Aug 10, 2026
    Award(A)
    Indirect
    12.8M shares-
  • Amneal Pharmaceuticals, Inc. logo
    AMRX

    Amneal Pharmaceuticals, Inc.

    Mar 14, 2025
    Sale(S)
    Indirect
    5M shares at avg. $8.35$41.8M

1-2 of 2

About Patel Tushar Bhikhubhai

Patel Tushar Bhikhubhai (SEC CIK 0001745375) files insider reports with the SEC as 10% Owner of Amneal Pharmaceuticals, Inc. (AMRX).

Signal8 holds 2 ownership filings by Patel Tushar Bhikhubhai, all Form 4s, filed between Mar 17, 2025 and Aug 12, 2026. Those filings report 2 transactions, from Mar 14, 2025 to Aug 10, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Patel Tushar Bhikhubhai's filings is in NEWPORT BEACH, CA.

Recent filings by Patel Tushar Bhikhubhai

  • Aug 10, 2026: Grant or award of AMRX shares (Form 4, code A).
  • Mar 14, 2025: Open-market sale of AMRX shares (Form 4, code S).

Other insiders filing for Amneal Pharmaceuticals, Inc. (AMRX)

How to read Form 4 transaction codes